Family Medicine Doctors in Charleston, MO Accepting Medicare
4 Family Medicine doctors found. Showing 1 - 4
 Dr. Robert Lee Robbins Jr., D.O. Family Medicine Medicare: Medicare Enrolled Practice Location: 112 W Commercial St, Charleston, MO 63834 Phone: 573-683-4010 Fax: 573-683-2167 |
Michael C Hakala, D.O. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 300 E Pedro Simmons Dr, C/o Secc, Charleston, MO 63834 Phone: 573-683-4409 |
Dr. Gregorio Lerma Rodriguez, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 1403 E. Marshall Street, Charleston, MO 63834 Phone: 573-683-2327 Fax: 573-683-2373 |
Jeffrey Griesemer, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1403 E Marshall St, Charleston, MO 63834 Phone: 573-683-2327 |
News Archive
BIDMC researcher receives Director's New Innovator award to study roots of hunger, cravings
Mark Andermann, PhD, a neuroendocrinology investigator at Beth Israel Deaconess Medical Center, has been awarded a prestigious Director's New Innovator award as part of the High Risk-High Reward grant program sponsored by the National Institute of Diabetes and Digestive and Kidney Disorders and the National Institutes of Health Common Fund.
Researchers adopt new approach to treating advanced prostate cancer
Scientists have proposed a new approach to preventing the proliferation of prostate tumor cells that are no longer responding to treatment. Prostate cancer can usually be cured via surgical removal of the tumor and/or the use of radiotherapy, but in one-fifth of cases, patients also require treatment with drugs to continue removing tumor cells. However, these drugs are only effective for up to three years, after which the cancer continues to develop.
Cardima announces CE Mark approval for Surgical Ablation Probe in Surgical Treatment of Atrial Fibrillation
Cardima, Inc., a medical device company focused on the treatment of atrial fibrillation (AF) and manufacturer of the Cardima Surgical Ablation System, today announced that it has received CE Mark approval with an Indication for the Surgical Treatment of Atrial Fibrillation for its Surgical Ablation Probe. All components of the Cardima Surgical Ablation System are now approved for marketing for the treatment of AF in European countries recognizing CE Mark approval.
Patrys receives FDA Orphan Medicinal Product Designation for PAT-SM6
Patrys Limited, a clinical stage biotechnology company, has received confirmation of Orphan Medicinal Product Designation for its lead anti-cancer product PAT-SM6, from the USA Food and Drugs Administration.
› Verified 7 days ago